| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Apr―16 |
Mast cell activation signature as a potential biomarker in COVID-19 |
Yatsiri G. Meneses-Preza, Rodolfo Soria-Castro, Ángel R. Alfaro-Doblado, Alejandro Hernández-Solis, Pablo Álvarez-Maldonado, Diana Gómez-Martín, Jiram Torres-Ruiz, José Francisco Muñoz-Valle, Guillermina Muñoz-Ríos, Cristian Oswaldo Hernández-Ramírez, Azmavet M. Güemes-González, Isabel Wong-Baeza, José Luis Maravillas-Montero, Sonia M. Pérez-Tapia, Alma D. Chávez-Blanco, Sergio Estrada-Parra, Rommel Chacón-Salinas |
| 2 |
[GO] |
2025―Mar―29 |
Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals |
Nicole Hartwig Trier, Nadia Zivlaei, Sisse Rye Ostrowski, Erik Sørensen, Margit Larsen, Rimantas Slibinskas, Evaldas Ciplys, Jette Lautrup Frederiksen, Gunnar Houen |
| 3 |
[GO] |
2025―Feb―09 |
Systemic and cerebrospinal fluid immune mediators coordinate a dichotomic microenvironment in parturients with acute or convalescent phases of COVID-19 |
Lizandra Moura Paravidine Sasaki, Maria Eduarda Canellas-de-Castro, Geraldo Magela Fernandes, Felipe Motta, David Alves de Araújo, Heidi Luise Schulte, Gabriela Profírio Jardim-Santos, Ângelo Pereira da Silva, Aleida Oliveira de Carvalho, Yacara Ribeiro Pereira, Clara Correia de Siracusa, Isadora Pastrana Rabelo, Agenor de Castro Moreirados Santos, Caroline de Oliveira Alves, Lucas Lauand, Rodrigo de Resende Nery, Dayde Lane Mendonça-Silva, Rosana Tristão, José Alfredo Lacerda de Jesus, Karina Nascimento Costa, Luiz Cláudio Gonçalves de Castro, Patricia Shu Kurizky, Otávio de Toledo Nóbrega, Laila Salmen Espindola, Jordana Grazziela Alves Coelho-dos-Reis, Joaquim Pedro Brito-de-Sousa, Ismael Artur Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, Andrea Teixeira-Carvalho, Ciro Martins Gomes, Cleandro Pires de Albuquerque, Alexandre Anderson de Sousa Munhoz Soares, Alberto Moreno Zaconeta, Olindo Assis Martins-Filho, Licia Maria Henrique da Mota |
| 4 |
[GO] |
2024―Sep―19 |
Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis |
Jenna M. Benoit, Jessica A. Breznik, Angela Huynh, Braeden Cowbrough, Barbara Baker, Lauren Heessels, Sumiya Lodhi, Elizabeth Yan, Hina Bhakta, Rumi Clare, Ishac Nazy, Jonathan L. Bramson, Maggie J. Larché, Dawn ME Bowdish |
| 5 |
[GO] |
2024―Jul―26 |
Real-world Effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among Children 5-11 years of age in Brazil: a prospective test-negative design study |
Cristina de Oliveira Rodrigues, Julia Spinardi, Regis Goulart Rosa, Maicon Falavigna, Emanuel Maltempi de Souza, Josélia Larger Manfio, Ana Paula de Souza, Cintia Laura Pereira de Araujo, Mírian Cohen, Gynara Rezende Gonzalez do Valle Barbosa, Fernanda Kelly Romeiro Silva, Daniel Sganzerla, Mariana Motta Dias da Silva, Diogo Ferreira, Nicolas Taciano Kunkel, Nathan Iori Camargo, Jean Carlos Sarturi, Márcia Cristina Guilhem, Jaqueline Carvalho de Oliveira, Caroline Cardoso Lopes, Fernanda Widmar, Letícia Killes Barufi, Gabrielle Nunes da Silva, Daniela Fiori Gradia, Ana Paula Carneiro Brandalize, Carla Adriane Royer, Rafael Messias Luiz, Valter Antonio Baura, Hellen Abreu, Carolina Gracia Poitevin, Gabriela Almeida Kucharski, Fernando Pedrotti, Srinivas Rao Valluri, Amit Srivastava, Viviane Wal Julião, Olga Chameh Melone, Kristen E. Allen, Moe H Kyaw, Graciela del Carmen Morales Castillo, John M McLaughlin |
| 6 |
[GO] |
2024―Jun―24 |
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade |
Priscilla S. Redd, Alyssa D Merting, John D. Klement, Dakota B. Poschel, Dafeng Yang, Kebin Liu |
| 7 |
[GO] |
2024―Jun―19 |
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients. |
Manuela Capone, Anna Vanni, Lorenzo Salvati, Giulia Lamacchia, Alessio Mazzoni, Laura Maggi, Lorenzo Cosmi, Francesco Liotta, Paola Romagnani, Luigi Cirillo, Elisa Buti, Vito Terlizzi, Chiara Azzari, Francesco Citera, Federica Barbati, Gian Maria Rossolini, Silvia Bresci, Beatrice Borchi, Annalisa Cavallo, Jessica Mencarini, Emanuela Francalanci, Seble Tekle Kiros, Alessandro Bartoloni, Francesco Annunziato |
| 8 |
[GO] |
2023―Nov―24 |
Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination |
Xiao-Yong Zhan, Hui Chen, Huimin Kong, Tongfei Meng, Jieyu Ye, Yong Liu, Margaret H.L. Ng, Liang Li, Yuming Zhang, Jinqi Huang, Qiang Peng, Chun Chen, Yulong He, Mo Yang |
| 9 |
[GO] |
2023―Sep―06 |
USE OF RECOMBINANT S1 PROTEIN WITH hFc FOR ANALYSIS OF SARS-COV-2 ADSORPTION AND EVALUATION OF DRUGS THAT INHIBIT ENTRY INTO VERO E6 CELLS |
Jéssica Carla Martins Couto, Taís Vidal, Eduardo Reichert Decker, Janio M Santurio, Carlos Fernando de Mello, Micheli Mainardi Pillat |
| 10 |
[GO] |
2023―Aug―18 |
Pre-infection antibody levels of vaccinated healthcare workers with SARS-CoV-2 breakthrough infection: A nested case-control study |
Sema Alp Çavuş, Muammer Çelik, Ahmet Furkan Süner, Irmak Güzel, Çağlar Irmak, Derya Çağlayan, Huriye Gamze Öztürk, Neslişah Şiyve, Özgür Appak, Elif Işık, Gül Ergör, Osman Alparslan Ergör, Yücel Demiral, Ayça Arzu Sayıner, Bülent Kılıç |
| 11 |
[GO] |
2023―Jun―18 |
Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection. |
Abdulraheem Y. Majeed, Nor Effa S. Zulkafli, Ali H. Ad'hiah |
| 12 |
[GO] |
2023―Jun―03 |
Myocarditis Development After COVID-19 Vaccination in an Immunodeficient Case |
Öner Özdemir, Elif Şeker, Ümmügülsüm Dikici, Muhammed Güneş |
| 13 |
[GO] |
2023―May―24 |
Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin |
Andy Ka Chun Kan, Philip Hei Li |
| 14 |
[GO] |
2023―Jan―23 |
Immunothrombosis biomarkers as potential predictive factors of acute respiratory distress syndrome in moderate-to-critical COVID-19: a single-center, retrospective cohort study |
Giou-Teng Yiang, Yao-Kuang Wu, Kuo-Wang Tsai, I-Shiang Tzeng, Wan-Chung Hu, Min-Tser Liao, Kuo-Cheng Lu, Hsueh-Wen Chung, You-Chen Chao, Wen-Lin Su |
| 15 |
[GO] |
2023―Jan―02 |
Does infection with Leishmania protect against Covid-19? |
Nasreddine Saidi, Refka Jelassi |
| 16 |
[GO] |
2022―Nov―13 |
COVID-19 Acute Respiratory Distress Syndrome promotes a specific alternative macrophage polarization |
Marc Garnier, Florian Blanchard, Arnaud Mailleux, Laurence Morand-Joubert, Bruno Crestani, Christophe Quesnel |
| 17 |
[GO] |
2022―Oct―21 |
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies |
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Andrea Carolina Machado-Sulbarán, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Beatriz Verónica Panduro-Espinoza, Jonathan Adrián Gallegos-Díaz de Leon, Carlos David Munguía-Ramirez, Jorge Hernández-Bello |
| 18 |
[GO] |
2022―Sep―27 |
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4+ T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer |
Marcus Odendahl, Iris Endler, Beate Haubold, Roman N. Rodionov, Stefan R. Bornstein, Torsten Tonn |
| 19 |
[GO] |
2022―Sep―27 |
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody. |
Danay Saavedra, Ana L. Añé-Kourí, Egda M. Llanez Gregorich, Jilma Mena, Patricia Lorenzo-Luaces, Henrry Diaz Londres, Aray Hernández Martinez, Jorge Jiménez Armada, Yamilka Hernández Sánchez, Yaneth Zamora González, Mayelin Troche, Loipa Medel, Mayra Ramos, Tania Crombet |
| 20 |
[GO] |
2022―Sep―13 |
Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule. |
Wagner Angelika, Anna Ohradanova-Repic, Laura Gebetsberger, Gabor Tajti, Kundi Michael, Stockinger Hannes, Ursula Wiedermann, Grabmeier-Pfistershammer Katharina |
| 21 |
[GO] |
2022―Aug―31 |
Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations |
Junpeng Ma, Han Bai, Tian Gong, Weikang Mao, Yijun Nie, Xuan Zhang, Yanyan Da, Xiaorui Wang, Hongyu Qin, Qiqi Zeng, Fang Hu, Xin Qi, Bingyin Shi, Chengsheng Zhang |
| 22 |
[GO] |
2022―Jul―14 |
Diminished T-cell Immune Responses to SARS-CoV-2 Omicron Variant after BNT162b2 Vaccination |
Stanley C. Jordan, Bong-Ha Shin, Edgar Rodriguez, Vo Ashley, Ruan Zhang |
| 23 |
[GO] |
2022―Jul―08 |
Soluble CD137 as a potential biomarker for severe COVID-19 |
Mariana de Oliveira Marques, André Abdo, Priscilla Brito Silva, Amilton Silva Junior, Lucas Bassolli de Oliveira Alves, José Victor Gomes Costa, Josiane Martin, Philip Bachour, Otavio C.G. Baiocchi |
| 24 |
[GO] |
2022―May―31 |
Could anti-ACE2 antibodies alter the results of SARS-CoV-2 Ab neutralization assays? |
Raquel Tobes |
| 25 |
[GO] |
2022―Feb―04 |
A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant. |
S.O Minka, F.H Minka |
| 26 |
[GO] |
2022―Jan―31 |
Immune system aging and the aging-related diseases in the COVID-19 era |
Jacek M. Witkowski |
| 27 |
[GO] |
2022―Jan―07 |
A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: effects on proteolytic cleavage and ACE2 binding |
Michael G. Spelios, Jeanne M. Capanelli, Adam W. Li |
| 28 |
[GO] |
2021―Sep―23 |
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients |
Rasha Abu-Eid, Frank James Ward |
| 29 |
[GO] |
2021―Jul―03 |
SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium |
Ye Zhou, Mu Wang, Yunhui Li, Peihui Wang, Ping Zhao, Zixuan Yang, Suyuan Wang, Liyuan Zhang, Zhenyang Li, Kaiwei Jia, Cuiping Zhong, Nan Li, Yizhi Yu, Jin Hou |
| 30 |
[GO] |
2021―Apr―24 |
Will a little change do you good? A putative role of polymorphisms in COVID-19 |
Adriana Alves Oliveira Paim, Ágata Lopes-Ribeiro, Daniele S.O. Daian e Silva, Luis Adan F. Andrade, Thais F. S Moraes, Edel F. Barbosa-Stancioli, Flávio Guimarães da Fonseca, Jordana G. Coelho-dos-Reis |
| 31 |
[GO] |
2021―Apr―24 |
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk |
Irene Bonaccorsi, Paolo Carrega, Emmanuele Venanzi Rullo, Rosaria Ducatelli, Michela Falco, Josè Freni, Massimiliano Miceli, Riccardo Cavaliere, Vincenzo Fontana, Antonio Versace, Gaetano Caramori, Antonio David, Giuseppe Nunnari, Guido Ferlazzo |
| 32 |
[GO] |
2021―Feb―10 |
Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection |
Jorge Quarleri, Cintia Cevallos, M. Victoria Delpino |
| 33 |
[GO] |
2021―Jan―11 |
Did we forget the diffuse chemosensory system when studying COVID-19? |
Sheila Veronese, Flavia Merigo, Andrea Sbarbati |
| 34 |
[GO] |
2021―Jan―08 |
Immune reactivity during COVID-19: Implications for treatment |
Claudio Napoli, Giuditta Benincasa, Clelia Criscuolo, Mario Faenza, Cinzia Liberato, Mariangela Rusciano |
| 35 |
[GO] |
2021―Jan―02 |
Are the emerging SARS-COV-2 mutations friend or foe? |
Adnan Ero |
| 36 |
[GO] |
2020―Nov―05 |
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab |
Lorenzo Salvati, Mariaelena Occhipinti, Leonardo Gori, Luca Ciani, Alessio Mazzoni, Laura Maggi, Manuela Capone, Paola Parronchi, Francesco Liotta, Vittorio Miele, Francesco Annunziato, Federico Lavorini, Lorenzo Cosmi |
| 37 |
[GO] |
2020―Sep―29 |
“Cytokine storm”, not only in COVID-19 patients. Mini-review |
Norbert Lukan |
| 38 |
[GO] |
2020―Jul―10 |
Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: crosstalk among calorie restriction, autophagy and immune response |
Md. Abdul Hannan, Md. Ataur Rahman, Md Saidur Rahman, Abdullah Al Mamun Sohag, Raju Dash, Khandkar Shaharina Hossain, Mithila Farjana, Md Jamal Uddin |
| 39 |
[GO] |
2020―Jun―20 |
Lymphopenia during the COVID-19 infection: What it shows and what can be learned |
Soheil Tavakolpour, Taha Rakhshandehroo, Erin X. Wei, Mohammad Rashidian |
| 40 |
[GO] |
2020―Jun―11 |
Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1’-phosphatase |
E. Thomas, Ramy Saad |
| 41 |
[GO] |
2020―Jun―06 |
How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? |
Malgorzata Kloc, Rafik M. Ghobrial, Jacek Z Kubiak |
| 42 |
[GO] |
2020―May―28 |
Are there any association between COVID-19 severity and immunosuppressive therapy? |
Ahmad Hormati, Mohammad Reza Ghadir, Farhad Zamani, Javad Khodadadi, Fatemeh Khodadust, Mahboubeh Afifian, Reza Aminnejad, Sajjad Ahmadpour |
|
